Q1 2023 13F Holders as of 31 Mar 2023
-
Type / Class
-
Debt / DBCV 1.500%11/1
-
Market price (% of par)
-
193.58%
-
Total 13F principal
-
$55,585,000
-
Principal change
-
-$319,568,898
-
Total reported market value
-
$107,801,451
-
Number of holders
-
24
-
Value change
-
-$599,358,216
-
Number of buys
-
10
-
Number of sells
-
26
Institutional Holders of SAREPTA THERAPEUTICS INC - DBCV 1.500%11/1 as of Q1 2023
As of 31 Mar 2023,
SAREPTA THERAPEUTICS INC - DBCV 1.500%11/1 was held by
24 institutional
bondholders
reporting positions in Form 13F filings.
These institutions reported holding
$55,585,000
in principal (par value) of the bond.
The largest 10 bondholders included
Point72 Asset Management, L.P., Opti Capital Management, LP, CSS LLC/IL, CAPSTONE INVESTMENT ADVISORS, LLC, TENOR CAPITAL MANAGEMENT Co., L.P., Aequim Alternative Investments LP, D. E. Shaw & Co., Inc., LORD, ABBETT & CO. LLC, PALISADE CAPITAL MANAGEMENT, LP, and FMR LLC.
This page lists
24
institutional bondholders reporting positions
for the Q1 2023 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price (% of par)
|
Principal |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.